Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
lighter decrease » slight decrease (Expand Search), slightly decreases (Expand Search), greater decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
lighter decrease » slight decrease (Expand Search), slightly decreases (Expand Search), greater decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
-
2101
-
2102
-
2103
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2104
-
2105
-
2106
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2107
-
2108
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2109
-
2110
-
2111
-
2112
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2113
-
2114
-
2115
-
2116
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2117
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2118
-
2119
-
2120
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: